Blocking receptor signals can help treat fibrosis

Medical Xpress - latest medical and health news stories ·
Health & Medicine United Kingdom

In an investigator-initiated trial, researchers have shown that inhibiting the cytokines IL-4 and IL-13 can prevent fibrosis in the skin disease localized scleroderma. These findings could pave the way for the prevention and treatment of other fibrotic conditions. The study "Interleukin 4 receptor-α blockade in localised scleroderma: a phase II proof-of-concept study" was published in the journal…

Read original article on Medical Xpress - latest medical and health news stories →